Want to see TSE:NLH full AI Analyst Report?
Nova Leap Health (NLH) Stock Statistics & Valuation Metrics
Total Valuation
Nova Leap Health has a market cap or net worth of CAD 43.66M. The enterprise value is CAD 42.23M.
- Market Cap
- CAD 43.66M
- Enterprise Value
- CAD 42.23M
Share Statistics
Nova Leap Health has 87,314,255 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 87,314,255
- Owned by Insiders
- 5.48%
- Owned by Institutions
- ―
Financial Efficiency
Nova Leap Health’s return on equity (ROE) is -0.01 and return on invested capital (ROIC) is 5.13%.
- Return on Equity (ROE)
- -0.01
- Return on Assets (ROA)
- -0.01
- Return on Invested Capital (ROIC)
- 5.13%
- Return on Capital Employed (ROCE)
- 0.06
- Revenue Per Employee
- 59.18K
- Profits Per Employee
- -357.092
- Employee Count
- 541
- Asset Turnover
- 1.37
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Nova Leap Health is 23.60. Nova Leap Health’s PEG ratio is -0.01.
- PE Ratio
- 23.60
- PS Ratio
- 0.94
- PB Ratio
- 1.62
- Price to FCF
- 16.09
- Price to Operating Cash Flow
- 16.37
- PEG Ratio
- -0.01
Income Statement
In the last 12 months, Nova Leap Health had revenue of 32.02M and earned -193.19K in profits. Earnings per share was -0.00.
- Revenue
- 32.02M
- Gross Profit
- 11.85M
- Operating Income
- 1.13M
- Pretax Income
- -134.36K
- Net Income
- -193.19K
- EBITDA
- 1.97M
- Earnings Per Share (EPS)
- -0.00
Cash Flow
In the last 12 months, operating cash flow was 1.91M and capital expenditures -243,016, giving a free cash flow of 1.95M billion.
- Operating Cash Flow
- 1.91M
- Free Cash Flow
- 1.95M
- Free Cash Flow per Share
- 0.02
Dividends & Yields
Nova Leap Health pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 6.23%
- Earnings Yield
- 4.24%
Stock Price Statistics
- Beta
- 0.31
- 52-Week Price Change
- 78.57%
- 50-Day Moving Average
- 0.51
- 200-Day Moving Average
- 0.41
- Relative Strength Index (RSI)
- 55.75
- Average Volume (3m)
- 21.13K
Important Dates
Nova Leap Health upcoming earnings date is Nov 05, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 07, 2026
- Next Earnings Date
- Nov 05, 2026
- Ex-Dividend Date
- ―
Financial Position
Nova Leap Health as a current ratio of 0.96, with Debt / Equity ratio of 15.39%
- Current Ratio
- 0.96
- Quick Ratio
- 0.96
- Debt to Market Cap
- 0.11
- Net Debt to EBITDA
- 0.73
- Interest Coverage Ratio
- 3.16
Taxes
In the past 12 months, Nova Leap Health has paid 58.82K in taxes.
- Income Tax
- 58.82K
- Effective Tax Rate
- -0.44
Enterprise Valuation
Nova Leap Health EV to EBITDA ratio is 12.64, with an EV/FCF ratio of 17.59.
- EV to Sales
- 1.03
- EV to EBITDA
- 12.64
- EV to Free Cash Flow
- 17.59
- EV to Operating Cash Flow
- 17.90
Balance Sheet
Nova Leap Health has CAD 1.44M in cash and marketable securities with CAD 4.45M in debt, giving a net cash position of -CAD 3.01M billion.
- Cash & Marketable Securities
- CAD 1.44M
- Total Debt
- CAD 4.45M
- Net Cash
- -CAD 3.01M
- Net Cash Per Share
- -CAD 0.03
- Tangible Book Value Per Share
- -CAD 0.01
Margins
Gross margin is 38.95%, with operating margin of 5.13%, and net profit margin of 3.99%.
- Gross Margin
- 38.95%
- Operating Margin
- 5.13%
- Pretax Margin
- 5.51%
- Net Profit Margin
- 3.99%
- EBITDA Margin
- 8.15%
- EBIT Margin
- 5.89%
Analyst Forecast
The average price target for Nova Leap Health is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 18.35%
- EPS Growth Forecast
- 1021.05%
Scores
- Smart Score
- ―
- AI Score
- 68